ASP5094

· Astellas Pharma Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ASP5094, covering 2024-10-31 to 2024-10-31. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of ASP5094 in Patients With Rheumatoid Arthritis on Methotrexate [Phase 2]

See pricing